Received Mar 2, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 3 | UNK | — |
Patient received first dose (16-June-2023) and second dose (24-Aug-2023) of Bexsero not yet received third dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a adult male patient who received Men B NVS (Bexsero) for prophylaxis. The patient's past medical history included asplenia (patient had asplenia before starting the vaccine scheme). Previously administered products included bexsero (patient received the first dose on 16-JUN-2023) and Bexsero (patient received the second dose on 24-AUG-2023). The patient did not receive the 3rd dose of Bexsero. The patient had incomplete course of vaccination (Verbatim: Patient received first dose (16-June-2023) and second dose (24-Aug-2023) of Bexsero not yet received third dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 24-FEB-2026 The reporter wanted to know if the patient needs to restart the series or just to provide the 3rd dose. The batch number was not provided and a request for this information has been made.
Medical History/Concurrent Conditions: Asplenia (patient had asplenia before starting the vaccine scheme)